Irinotecan
Camptosar, Onivyde
Topoisomerase Inhibitor
NADAC/unit
N/A
No Shortage
15 Manufacturers
35 ANDAs
Active Shortages
2026-02-24 A business decision was made to discontinue manufacture of the drug., Ingenus Pharmaceuticals LLC
2026-02-24 A business decision was made to discontinue manufacture of the drug., Ingenus Pharmaceuticals LLC
2025-09-26 Discontinuation of the manufacture of the drug; Distributed by Sagent Pharmaceuticals, Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
2025-09-26 Discontinuation of the manufacture of the drug; Distributed by Sagent Pharmaceuticals, Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
2025-08-04 Product not anticipated to be available beyond mid-late October 2025, Teva Pharmaceuticals USA, Inc.
Generic Manufacturers
ACCORD HEALTHCARE INCACTAVIS TOTOWA LLCEPIC PHARMA LLCEUGIA PHARMA SPECIALITIES LTDFRESENIUS KABI USA LLCGLAND PHARMA LTDHIKMA FARMACEUTICA (PORTUGAL) SAHIKMA PHARMACEUTICALS USA INCHOSPIRA INCINTAS PHARMACEUTICALS USAIPSEN BIOPHARMACEUTICALS INCNOVAST LABORATORIES LTDPFIZER INCPHARMOBEDIENT CONSULTING LLCQILU PHARMACEUTICAL HAINAN CO LTDSHILPA MEDICARE LTDTEVA PHARMACEUTICALS USA
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.